|
![]() |
Prostate Cancer > Angiogenesis
The following information is about Angiogenesis.
Angiogenesis Defined
The growth of new blood vessels; a characteristic of tumors; angiogenesis is normal biologic process that occurs in both healthy and disease states; “angiogenesis factor” or “tumor angiogenesis factor” refers to a substance that tumors produce in order to grow new blood vessels
This definition is in context to Prostate Cancer. See more contextual defintions for Angiogenesis.
2009 Dr. Paul Janssen Award For Biomedical Research Won By Axel Ullrich
Published July 2, 2009, 8:09 am, Medical News Today
Johnson & Johnson has announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin® (trastuzumab) , is the winner of the 2009 Dr. Paul Janssen Award for Biomedical Research. An independent committee of world-renowned scientists selected Dr.
Pfizer Discontinues Phase 3 Trial Of Sutent(R) In Metastatic Colorectal Cancer
Published July 2, 2009, 4:09 am, Medical News Today
Pfizer Inc announced the discontinuation of the SUN 1122 Phase 3 trial that evaluated Sutent® (sunitinib malate) plus FOLFIRI (irinotecan plus infusional 5-fluorouracil and leucovorin) versus FOLFIRI alone for the first-line treatment of metastatic colorectal cancer (CRC).
02.07.2009 - DJ DGAP-Adhoc: TopoTarget completes fully subscribed rights issue
Published July 2, 2009, 12:44 am, 4investors
Release of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. =--------------------------------------------------------------------------
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
Published July 1, 2009, 11:30 am, redOrbit
LONDON, July 1 /PRNewswire/ -- Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin(R) (trastuzumab)*, is the winner of the 2009 Dr.
Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research
Published July 1, 2009, 10:14 am, EurekAlert!
( Porter Novelli ) Johnson & Johnson announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin (trastuzumab), is the winner of the 2009 Dr. Paul Janssen Award for Biomedical Research. An independent committee of world-renowned scientists ...
Sutent Significantly Improved Progression-Free Survival For Patients With Advanced Pancreatic Islet Cell Tumours
Published July 1, 2009, 4:08 am, Medical News Today
Pfizer announced preliminary results from a randomized Phase 3 trial of Sutent (sunitinib malate) in patients with advanced pancreatic islet cell tumours, also known as pancreatic neuroendocrine tumours, which is a different type of cancer than the more common pancreatic adenocarcinoma. Study findings demonstrated that median progression-free survival (PFS) was 11.
European Regulator Gives Positive Opinion for the use of Avastin in Combination With docetaxel for the First-Line ...
Published June 28, 2009, 7:39 pm, Thaipr.net
Patients with advanced (metastatic) breast cancer will be able to benefit from treatment with Avastin (bevacizumab) as a result of a new broader label recommendation in Europe, Roche announced today.
Are you looking for additional Prostate Cancer > Angiogenesis news? Try our new "Angiogenesis News Focus" area.
Off-site Angiogenesis Links, User Submitted
The following links have been collected through user bookmark submission in the Angiogenesis category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Sun Jun 28
- Down Syndrome Yields Key Cancer Clue: People with Down syndrome rarely get solid tumors -- and now researchers are learning why. The answers point to new cancer treatments.
Wed Jun 24
Mon Jun 22
- Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature: has a nice summary table of studies - but if they are all as unclear as the Mittal study....
- Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovasculariza tion ? Genes & Development: from the shape - the cells look more like macrophages than mature endothelial cells - very suspicious
Sat Jun 13
- Discovery of new angiogenesis protein - possible cancer drug target
- In vivo properties of the proangiogenic peptide QK
Thu Jun 11
- Gene Therapy Technique Thwarts Cancer By Cutting Off Tumor Blood Supply: ScienceDaily (June 11, 2009) ? University of Florida researchers have come up with a new gene therapy method to disrupt cancer growth by using a synthetic protein to induce blood clotting that cuts off a tumor's blood and nutrient supply. In mice implanted with human colorectal cancer cells, tumor volume decreased 53 percent and cancer cell growth slowed by 49 percent in those treated with a gene that encodes for the artificial protein, compared with those that were untreated.
Wed Jun 10
- UNC scientists identify growth factor as possible cancer drug target: Scientists at the UNC Lineberger Comprehensive Cancer Center report finding a new angiogenesis protein, SFRP2, found in the blood vessels of numerous tumor sites, including breast prostate, lung, pancreas, ovarian, colon, kidney tumors, and angiosarcomas. The scientists found that SFRP2 is a potent stimulator of angiogenesis. This protein may be a favorable target for inhibiting angiogenesis which would then "starve&q uot; the tumor of its blood supply, thus destroying the cancer.
Mon Jun 8
- Biomechanical regulation of blood vessel growth during tissue vascularizatio n : Article : Nature Medicine: an additional method for initial angiogenesis - pulling the existing vessels into the healing wound! Maybe more relevant for normal wound healing than tumors - or not?
Thu May 28
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Angiogenesis. If you would like to find related tags we recommend Tag Patterns > Angiogenesis
Off-site Angiogenesis Research Links
If you still need additional information on Angiogenesis then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
- A9 > Angiogenesis
- Alexa > Angiogenesis
- Anti-Aging Revolution > Angiogenesis
- DMOZ > Angiogenesis
- Feeds Filtered > Angiogenesis
- Google > Angiogenesis
- News Meme > Angiogenesis
- Nuah: News > Angiogenesis
- The Feed Directory > Angiogenesis
- OBP > Angiogenesis
- Open Tag Directory > Angiogenesis
- Podzy > Angiogenesis
- Yahoo > Angiogenesis
Prostate Cancer Topics
Everything you need to know about Prostate Cancer
Prostate Cancer
If you know the Prostate Cancer Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Prostate-Cancer.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
License
This work is licensed under Creative Commons.
